Mesothelioma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a cancer that your doctor has recommended treating with a precise, targeted form of radiation called stereotactic body radiation therapy (SBRT).
- Your tumor is no larger than 7 centimeters (about the size of a small apple).
- You are 18 years of age or older.
- You are well enough to carry out basic daily activities — your doctor can assess this using a standard health scale (confirm with trial site).
- You are able to understand and willing to sign a written consent form to participate.
- There may be additional eligibility requirements depending on where in the body your cancer is located (confirm with trial site).
Who may not be able to join:
- You have had an allergic reaction to a dye called gadolinium, which is sometimes used during MRI scans (this may not apply if you would not receive the dye — confirm with trial site).
- You are currently pregnant.
- You experience severe claustrophobia or anxiety that would make it difficult to be in an enclosed space.
- You are unable to have an MRI scan for any reason.
- There may be additional reasons related to where your cancer is located that could affect eligibility (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jonathan Leeman, MD, Brigham and Women's Hospital
Phone: 617-732-6452
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Delivery Success Rate for SMART across multiple tumors-Phase I; Tumor visualization-Phase I; Plan creation-Phase I; Rate of Improvement in Tumor Control-Phase II
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.